$75M Funding Will Help TreeFrog Develop Stem Cell Therapies

TreeFrog Therapeutics has raised $75 million in financing to support the clinical development of its stem cell-derived cell therapies for Parkinson’s disease, the company said in a press release.The new financing round, which brings the total funding to date to $83 million, will allow the company to use its C-Stem technology to expand the growth of [...]

Published September 17, 2021 at 11:55AM. Read full article at Stem Cells in the News Portal.